Endevica Bio Launches Phase 2 Trial for B07, a Potential Breakthrough Treatment to Prevent Weight Loss in Cancer Patients

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced the dose administration for the first patient in a Phas...

April 18, 2025 | Friday | News
President Trump Signs Executive Order to Lower Drug Prices, Focuses on Medicare Negotiations and Pharmacy Benefit Manager Reforms

President Trump issued an Executive Order titled Lowering Drug Prices by Once Again Putting Americans First on Tuesday, April 15. The Executive O...

April 18, 2025 | Friday | News
Actum Launches New Life Sciences Platform, Taps Top Industry Leaders to Tackle Biopharma’s Critical Challenges

Actum Pharma (Actum), a strategy and operating business partner to global biopharma manufacturers, today announces two executive appointments to launch a...

April 18, 2025 | Friday | News
Thermo Fisher Opens Doors to the Future of Cell Therapy Manufacturing in Carlsbad

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from researc...

April 18, 2025 | Friday | News
Pfizer Applauds CDC Panel’s Expanded Recommendation for RSV Vaccination in At-Risk Adults Aged 50–59

Pfizer Inc. announced  that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) vote...

April 17, 2025 | Thursday | News
Tariff hikes call for CPOs to keep reputational issues and costs down

At this stage, it is unknown just how much America’s new 10% tariff on the UK will cost the pharmaceutical industry. However, given that these levi...

April 17, 2025 | Thursday | News
White House Fires First Shot in Global Pharma Trade War: National Security Probe Targets Imported Drugs

    The Trump administration has launched a bold and controversial national security investigation into America’s heavy reliance on impor...

April 17, 2025 | Thursday | Reports
Biocon Biologics Clears U.S. Path for Interchangeable Aflibercept Biosimilar Yesafili Through Regeneron Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd announced  a settlement and license agreement...

April 16, 2025 | Wednesday | News
Hyperfine Enrolls First Patients in Landmark Study Comparing Portable and High-Field MRI in Neurology

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered porta...

April 16, 2025 | Wednesday | News
Radiance Biopharma Doses First Patient in China in Phase 1 Trial of ROR-1 Targeting ADC RB-164™

Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjug...

April 16, 2025 | Wednesday | News
Certara Launches Non-Animal Navigator™ to Accelerate Ethical, Predictive Drug Development

Certara, Inc. a global leader in model-informed drug development, announced the launch of its Non-Animal Navigator™ solution designed to help bi...

April 16, 2025 | Wednesday | News
Celltrion’s YUFLYMA® Granted FDA Interchangeable Biosimilar Status to Humira®

Celltrion, Inc. announced that the U.S. Food and Drug Administration (FDA) has designated YUFLYMA® (adalimumab-aaty), as an interchangeable biosim...

April 15, 2025 | Tuesday | News
INVO Fertility Rebrands and Refocuses on Fertility Services, Separates Oncology Operations

INVO Fertility, Inc., formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment t...

April 15, 2025 | Tuesday | News
Sandoz Sues Amgen in US Antitrust Case Over Enbrel® Patent Practices

Sandoz , the global leader in generic and biosimilar medicines,  announced the filing of an antitrust lawsuit in the US against Amgen, Inc. (Amgen),...

April 14, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close